# Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

> **NCT00016185** · PHASE1 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** alvocidib
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00016185
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2003-02
- **Final completion:** 2005-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016185, "Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00016185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*